Prismasol 2 mmol/l Potassium solution for haemodialysis/haemofiltration Irland - engelsk - HPRA (Health Products Regulatory Authority)

prismasol 2 mmol/l potassium solution for haemodialysis/haemofiltration

gambro lundia ab - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; chloride; lactate; hydrogen carbonate; potassium; glucose - solution for haemodialysis/haemofiltration - 2 millimole(s)/litre - hemofiltrates

Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

potassium chloride 0.15% w/v & sodium chloride 0.9% w/v solution for infusion

fresenius kabi limited - potassium chloride; sodium chloride - solution for infusion - 0.15% w/v + 0.9% w/v percent weight/volume - solutions affecting the electrolyte balance; electrolytes

Potassium Chloride 0.3% w/v & Sodium Chloride 0.9% w/v Solution for Infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

potassium chloride 0.3% w/v & sodium chloride 0.9% w/v solution for infusion

fresenius kabi limited - potassium chloride; sodium chloride - solution for infusion - 0.3% w/v + 0.9% w/v percent weight/volume - solutions affecting the electrolyte balance; electrolytes

SODIUM CHLORIDE INJECTION 0.9% 20 mL ampoule Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sodium chloride injection 0.9% 20 ml ampoule

interpharma pty ltd - sodium chloride, quantity: 9 mg/ml - injection, solution - excipient ingredients: water for injections - sodium chloride injection bp 0.9% can be used as the vehicle for many parenteral drugs and as an electrolyte replenisher for maintenance or replacement of deficits of extracellular fluid. it can also be used as a sterile irrigation medium.

SODIUM CHLORIDE INJECTION 0.9% 5 mL ampoule Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sodium chloride injection 0.9% 5 ml ampoule

interpharma pty ltd - sodium chloride, quantity: 9 mg/ml - injection, solution - excipient ingredients: water for injections - sodium chloride injection bp 0.9% can be used as the vehicle for many parenteral drugs and as an electrolyte replenisher for maintenance or replacement of deficits of extracellular fluid. it can also be used as a sterile irrigation medium.

SODIUM CHLORIDE INJECTION 0.9% 10 mL ampoule Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sodium chloride injection 0.9% 10 ml ampoule

interpharma pty ltd - sodium chloride, quantity: 9 mg/ml - injection, solution - excipient ingredients: water for injections - sodium chloride injection bp 0.9% can be used as the vehicle for many parenteral drugs and as an electrolyte replenisher for maintenance or replacement of deficits of extracellular fluid. it can also be used as a sterile irrigation medium.

Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.45% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6024) Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 20 mmol potassium chloride, 5% glucose and 0.45% sodium chloride injection for intravenous infusion 1000 ml bag (ahb6024)

baxter healthcare pty ltd - potassium chloride, quantity: 1.49 g/l; glucose, quantity: 50 g/l; sodium chloride, quantity: 4.5 g/l - injection - excipient ingredients: water for injections - the potassium chloride, sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.9% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6066) Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 20 mmol potassium chloride, 5% glucose and 0.9% sodium chloride injection for intravenous infusion 1000 ml bag (ahb6066)

baxter healthcare pty ltd - potassium chloride, quantity: 1.49 g/l; glucose, quantity: 50 g/l; sodium chloride, quantity: 9 g/l - injection - excipient ingredients: water for injections - the potassium chloride, sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

SODIUM FERRIC GLUCONATE COMPLEX- sodium ferric gluconate complex injection USA - engelsk - NLM (National Library of Medicine)

sodium ferric gluconate complex- sodium ferric gluconate complex injection

actavis pharma, inc. - sodium ferric gluconate complex (unii: cc9149u2qx) (ferric cation - unii:91o4lml611) - ferric cation 12.5 mg in 1 ml - sodium ferric gluconate complex in sucrose injection is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. - known hypersensitivity to sodium ferric gluconate or any of its components. pregnancy category b there are no adequate and well-controlled studies with sodium ferric gluconate complex in sucrose injection in pregnant women. reproduction studies have been performed in mice at doses up to 100 mg/kg/day (300 mg/m2 /day) and in rats at up to 20 mg/kg/day (120 mg/m2 /day). the doses in mice and rats are 4 and 1.5 times the human dose of 125 mg/day (77 mg/m2 /day) on a body surface area basis and have revealed no evidence of harm to the fetus due to sodium ferric gluconate complex in sucrose injection. because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly need

OSMOPREP- sodium phosphate, monobasic, monohydrate, sodium phosphate, dibasic anhydrous tablet USA - engelsk - NLM (National Library of Medicine)

osmoprep- sodium phosphate, monobasic, monohydrate, sodium phosphate, dibasic anhydrous tablet

salix pharmaceuticals, inc. - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, monobasic, monohydrate 1.102 g - osmoprep® is indicated for cleansing of the colon as a preparation for colonoscopy in adults. osmoprep is contraindicated in the following conditions: risk summary there are no available data on sodium phosphate use in pregnant women to inform a drug-associated risk for adverse developmental outcomes. animal reproduction studies have not been conducted with sodium phosphate. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary there are no data available to assess the presence of sodium phosphate in human milk, the effects of the drug on the breastfed infant, or the effects of the drug on milk production. the lack of clinical data during lactation precludes a clear determinat